IP Library › Granted Patent US 10,893,962
Granted Patent B2
US 10,893,962 · App. 16/877,287 · Granted Jan 19, 2021

Growth stent and valve for congenital narrowings

Inventors: Dustin Armer (Costa Mesa, CA); Eason Abbott (Santa Monica, CA)
Assignee: RENATA MEDICAL, INC.
A61F2/915A61F2/95A61F2/07A61F2/243A61F2/2418A61F2/82A61F2/90A61F2/958A61F2002/91558A61F2002/91575A61F2210/0014A61F2210/0057A61F2230/0069A61F2250/001A61F2250/0039A61F2250/0082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,893,962
App. No.
16/877,287
Granted
Jan 19, 2021
Kind
B2
Abstract

A growth stent and valve and methods for making and using the same. The growth stent and valve may be delivered to treat early stage congenital lesions, while expanding to adult vessel diameters. In selected embodiments, the growth stent and valve can comprise a frame and may have a covering on some portion to prevent blood flow through a wall of the frame. The growth stent and valve advantageously can maintain radial strength across an entire range of diameters necessary to treat a narrowed lesion from birth and childhood through adulthood as the vessels grow over the lifetime of a patient.

Claims (43)

1. A catheter insertable and re-expandable growth stent for implantation in a neonate patient, comprising:

an elongated stent frame with a plurality of frame struts each extending continuously from a proximal end region of said stent frame to a distal end region of said stent frame, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which said elongated stent frame expands via a delivery catheter from an initial state for facilitating insertion via the delivery catheter into a selected lumen of the neonate patient to a first stable expanded state being configured to support the selected lumen at implantation, said stent frame in the first expanded state defining an internal channel with a first cross-section,

wherein said stent frame is configured to be re-expanded via subsequent introduction of a dilation catheter from the first expanded state to a second stable expanded state as the patient grows, said stent frame in the second expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section.

2. The growth stent of claim 1 , wherein the initial state is less than 8 French, the first cross-section is less than 10 millimeters or both.

3. The growth stent of claim 1 , wherein said stent frame is configured to be re-expanded to the second expanded state after the neonate patient grows to become a child.

4. The growth stent of claim 3 , wherein the second cross-section is between 8 millimeters and 15 millimeters, inclusive.

5. The growth stent of claim 1 , wherein at least two of the frame struts have different strut widths.

6. The growth stent of claim 1 , wherein the internal channel extends between the proximal and distal end regions of said stent frame, at least one of the end regions being flared radially outwardly for facilitating an engagement between said stent frame and the selected lumen or being flared radially inwardly or being dulled for reducing risk of an aneurism in the selected lumen.

7. The growth stent of claim 1 , wherein said stent frame includes a fluid-impermeable covering for preventing leaks due to ingrowth of the selected lumen as the patient grows.

8. The growth stent of claim 1 , wherein said elongated stent frame is made of stainless steel, cobalt chromium, a polymer or a combination thereof.

9. The growth stent of claim 1 , wherein the intermediate frame cells are enclosed by the adjacent frame struts.

10. The growth stent of claim 9 , wherein two pairs of the adjacent frame struts intersect to define one of the intermediate frame cells and to form a plurality of the strut junctions.

11. The growth stent of claim 1 , wherein said stent frame is configured to further expand from the second expanded state to a third stable expanded state as the patient further grows, said stent frame in the third stable expanded state continuing to support the selected lumen and defining the internal channel with a third cross-section being larger than the second cross-section.

12. The growth stent of claim 11 , wherein said stent frame is configured to be expanded to the third expanded state after the patient grows to become an adult.

13. The growth stent of claim 11 , wherein the third cross-section is between 18 millimeters and 24 millimeters, inclusive.

14. A method for implanting a catheter insertable and re-expandable growth stent in a neonate patient, comprising:

inserting an elongated stent frame into a selected lumen of the neonate patient via a delivery catheter, the elongated stent frame being in an initial state for facilitating insertion and having a plurality of frame struts each extending continuously from a proximal end region of the stent frame to a distal end region of the stent frame; and

expanding the elongated stent frame via the delivery catheter from the initial state to a first stable expanded state to support the selected lumen, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which the elongated stent frame expands, the stent frame in the first expanded state defining an internal channel with a first cross-section,

wherein the stent frame is re-expanded via subsequent introduction of a dilation catheter from the first expanded state to a second stable expanded state as the patient grows, the stent frame in the second expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section.

15. The method of claim 14 , wherein the elongated stent frame is inserted via the delivery catheter, the delivery catheter being a balloon catheter delivery system.

16. A catheter insertable and re-expandable growth valve for implantation in a neonate patient, comprising:

an elongated valve frame with a plurality of frame struts each extending continuously from a proximal end region of said valve frame to a distal end region of said valve frame, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which said elongated valve frame expands via a delivery catheter from an initial state for facilitating insertion via the delivery catheter into a selected lumen of the neonate patient to a first stable expanded state being configured to support the selected lumen at implantation, said valve frame in the first expanded state defining an internal channel with a first cross-section; and

a plurality of leaflets extending from said valve frame into the internal channel,

wherein said valve frame is configured to be re-expanded via subsequent introduction of a dilation catheter from the first expanded state to a second stable expanded state as the patient grows, said valve frame in the second expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section, and

wherein said leaflets provide a valvular function in the first and second expanded states.

17. The growth valve of claim 16 , wherein the initial state is less than 8 French, the first cross-section is less than 10 millimeters or both.

18. The growth valve of claim 16 , wherein said valve frame is configured to be re-expanded to the second expanded state after the neonate patient grows to become a child.

19. The growth valve of claim 18 , wherein the second cross-section is between 8 millimeters and 15 millimeters, inclusive.

20. The growth valve of claim 16 , wherein the frame struts have a uniform strut width.

21. The growth valve of claim 16 , wherein the internal channel extends between the proximal and distal end regions of said valve frame, at least one of the end regions being flared radially outwardly for facilitating an engagement between said valve frame and the selected lumen or being flared radially inwardly or being dulled for reducing risk of an aneurism in the selected lumen.

22. The growth valve of claim 16 , wherein said valve frame includes a fluid-impermeable covering for preventing leaks due to ingrowth of the selected lumen as the patient grows.

23. The growth valve of claim 16 , wherein said elongated valve frame is made of stainless steel, cobalt chromium, a polymer or a combination thereof.

24. The growth valve of claim 16 , wherein the intermediate frame cells are enclosed by the adjacent frame struts.

25. The growth valve of claim 24 , wherein two pairs of the adjacent frame struts intersect to define one of the intermediate frame cells and to form a plurality of the strut junctions.

26. The growth valve of claim 16 , wherein said valve frame is configured to further expand from the second expanded state to a third stable expanded state as the patient further grows, said valve frame in the third stable expanded state continuing to support the selected lumen and defining the internal channel with a third cross-section being larger than the second cross-section.

27. The growth valve of claim 26 , wherein said valve frame is configured to be expanded to the third expanded state after the patient grows to become an adult.

28. The growth valve of claim 26 , wherein the third cross-section is between 18 millimeters and 24 millimeters, inclusive.

29. A method for implanting a catheter insertable and re-expandable growth valve in a neonate patient, comprising:

inserting an elongated valve frame into a selected lumen of the neonate patient via a delivery catheter, the elongated valve frame being in an initial state for facilitating insertion and having a plurality of frame struts each extending continuously from a proximal end region of the valve frame to a distal end region of the valve frame; and

expanding the elongated valve frame via the delivery catheter from the initial state to a first stable expanded state to support the selected lumen, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which the elongated valve frame expands, the valve frame in the first expanded state defining an internal channel with a first cross-section, a plurality of leaflets extending from said valve frame into the internal channel,

wherein the valve frame is re-expanded via subsequent introduction of a dilation catheter from the first expanded state to a second stable expanded state as the patient grows, the valve frame in the second expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section, and

wherein the leaflets provide a valvular function in the first and second expanded states.

30. The method of claim 29 , wherein the elongated valve frame is inserted via the delivery catheter, the delivery catheter being a balloon catheter delivery system.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE STREET ADDRESS FROM 4975 MACARTHUR COURT, SUITE 1150 TO 4675 MACARTHUR COURT, SUITE 1150 PREVIOUSLY RECORDED AT REEL: 69416 FRAME: 626. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 5, 2024
From: EDWARDS LIFESCIENCES CORPORTION
To: RENATA MEDICAL, INC.
Reel/Frame 069516/0830 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: EDWARDS LIFESCIENCES CORPORTION
To: RENATA MEDICAL, INC.
Reel/Frame 069416/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2024
From: NIA, NIMA V.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 069350/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2024
From: EDWARDS LIFESCIENCES CORPORTION
To: RENATA MEDICAL, INC.
Reel/Frame 069350/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2020
From: ARMER, DUSTIN; ABBOTT, EASON
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 053469/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2020
From: EDWARDS LIFESCIENCES CORPORATION
To: RENATA MEDICAL, INC.
Reel/Frame 053469/0903 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2020
From: ARMER, DUSTIN; ABBOTT, EASON
To: RENATA MEDICAL, INC.
Reel/Frame 052692/0710 →
Continuity (3)
Continuation 16441201 · Jun 14, 2019
Provisional Application 62811875 · Feb 28, 2019
Related Publication 20200276037A1 · Sep 3, 2020